Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

Biological Psychiatry

Volumn 40, Issue 1, 1996, Pages 14-18

  Fujimoto, Toshiro ^a   Nakano, Toshihiko ^a   Takano, Tetsuya ^a   Takeuchi, Kozo ^a   Yamada, Koichiro ^b   Fukuzako, Tsuyoshi ^b   Akimoto, Haruo ^c  

^a Fujimoto Hospital   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

Author keywords

N acetyl aspartate; Phosphocholine; Proton MRS; Schizophrenia; Trimethylamine

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID; PHOSPHOLIPID;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA;

EID: 0029894650     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00316-9     Document Type: Article

References (26)

1. Andreasen NC (1983): The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa.
2. Barker PB, Breiter SN, Soher BJ, Chatham JC, Forder JR, Samphilipo MA, Magee CA, Anderson JH (1994): Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 32:157-163.
3. 1H NMR study of cerebral development in the rat. NMR Biomed 2:225-229.
4. Brancati A, D'Arcangelo P (1991): Effects evoked by pentamethylenetetrazol-induced seizures upon N-acetylaspartate and N-acetylaspartylglutamate levels in different regions of the rat neuraxis. Life Sci 48:2229-2232.
5. 1H magnetic resonance spectroscopy of frontal and temporal lobe metabolism in schizophrenia. Schizophr Res 9:194.
6. 2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 47:213-219.
7. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R (1989): Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11:47-63.
8. Fujimoto T, Yokoyama Y, Okada A, Kanemaru R, Kihara Y (1985): T1 measurement in schizophrenic disorders. Jpn J Med Imag 4:1033-1039.
9. 31P chemical shift imaging. Proc Soc Magn Reson Med 11:1935.
10. 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 86:455-462.
11. 1H NMR markers of neuronal and glial disorders. NMR Biomed 2:196-200.
12. 31P NMR spectroscopy of the developing rat brain. Magn Reson Med 23:31-36.
13. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW (1993): Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 34:788-794.
14. Jernigan TL, Zisook S, Heaton RK, Moranville JT, Hesselink JR, Braff DL (1991): Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 48:881-890.
15. Kreis R, Ernst T, Ross BD (1993): Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30:424-437.
16. 76Br-bromolisuride. Br J Psychiatry 158:346-350.
17. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4:47-52.
18. Moore CM, Redmond OM, Buckley P, Larkin C, Stack JP, Waddington J, Ennis JT (1992): In vivo proton NMR spectroscopy (STEAM) in patients with schizophrenia. Proc Soc Magn Reson Med 11:1933.
19. 1H MRS) of the hippocampal formation in schizophrenia: A pilot study. Br J Psychiatry 165:481-485.
20. Overall JE, Gorham DR (1962): The brief psychiatric rating scale. Psychol Rep 10:799-812.
21. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations. J Neuropathol Exp Neurol 46:419-430.
22. Pettegrew JW, Keshavan MS, Panchalingan K, Strychor S, Kaplan DB, Tretta MG, Allen M (1991): Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch Gen Psychiatry 48:563-568.
23. Sauter R, Schneider M, Wicklow K, Kolem H (1992): Current status of clinically relevant techniques in magnetic resonance spectroscopy. Electromedica 60:32-54.
24. Wagner HN, Weinberger DR, Kleinman JE (1988): Neuroimaging and neuropathology. Schizophr Bull 14:383-397.
25. 2 dopamine receptors in drug-naive schizophrenics. Science 234:1558-1563.
26. 1H spectroscopy of the temporal lobes in schizophrenic and bipolar patients. Proc Soc Magn Reson Med 12:1539.